NDC 73540-003
Yakkongmo treatment
Pyrithione Zinc, Dexpanthenol, Niacinamide, Biotin
Yakkongmo treatment is a Topical Liquid in the Human Otc Drug category.  It is labeled and distributed by Bobsnu Co., Ltd.. The primary component is Salicylic Acid; Pyrithione Zinc; Dexpanthenol.
| Product ID | 73540-003_9f273fc5-32f9-a1b9-e053-2995a90aa870 | 
| NDC | 73540-003 | 
| Product Type | Human Otc Drug | 
| Proprietary Name | Yakkongmo treatment | 
| Generic Name | Pyrithione Zinc, Dexpanthenol, Niacinamide, Biotin | 
| Dosage Form | Liquid | 
| Route of Administration | TOPICAL | 
| Marketing Start Date | 2020-02-22 | 
| Marketing Category | UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER | 
| Labeler Name | BOBSNU CO., LTD. | 
| Substance Name | SALICYLIC ACID; PYRITHIONE ZINC; DEXPANTHENOL | 
| Active Ingredient Strength | 0 g/100mL; g/100mL; g/100mL | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2021-12-31 |